The safety and efficacy of Privigen were studied in PI, CIDP, and chronic ITP. See the results.
Hear some success stories of patients treated with Privigen from PI experts Carla Duff, ARNP*, and Mark Stein, MD.
*Carla Duff is currently an employee of CSL Behring. When this video was produced, Ms. Duff was an Advanced Registered Nurse Practitioner with John Hopkins All Children Hospital in Saint Petersburg, Florida.
Proline was specifically chosen after extensive testing and analysis.
CSL Behring has been fractionating human plasma for more than 65 years, employing an expert team of virologists and quality assurance systems and controls that are among the most rigorous and comprehensive in the industry.
The manufacturing process for Privigen has been modified to include an immunoaffinity chromatography step called Ig IsoLo® that reduces levels of anti-A and anti-B antibodies while still retaining other beneficial components.